GoodRx Holdings Return on Equity

GoodRx Holdings (GDRX) currently reports a ROE of 13.13%. That is below the Technology sector average of 47.89%. Use the charts on this page to explore GoodRx Holdings's ROE history and peer comparisons.

GoodRx Holdings's ROE of 13.13% is lower than the Technology sector average of 47.89%. That is roughly 72.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but GoodRx Holdings's current 13.13% should be judged against Technology norms (sector average: 47.89%) and against GDRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 13.13%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.89%. From there, open related valuation or income-statement pages for GoodRx Holdings, and consider following GDRX for alerts when major investors trade the stock.

GoodRx Holdings is classified in the Technology sector. On ROE, it currently shows 13.13% versus a sector average near 47.89%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing GDRX with unrelated industries.